A selection of resources to help addiction and harm reduction specialists who are interested in screening and treating patients with HCV.
Some links below go to third-party content. AbbVie makes no representations as to the accuracy of their content and their inclusion is not an endorsement of those organizations by AbbVie or by those organizations of AbbVie or this website.
◄ ◄ ◄ ◄ SWIPE TO SEE MORE OPTIONS ► ► ► ►
HCV Epidemiology Animation
Upload date: 04/21/2021 | Duration: 02:07
Background information on the changing epidemiology of HCV in recent years with a particular focus on the increasing prevalence of PWID who...
Background information on the changing epidemiology of HCV in recent years with a particular focus on the increasing prevalence of PWID who are presenting with infection. This also includes details on barriers to care among PWID and the importance of simplifying the treatment cascade.
Treating Vulnerable Populations
Upload date: 04/21/2021 | Duration: 02:09
A description of the importance of finding new and inventive ways to engage vulnerable patients in HCV care from the perspective of a clinical…
A description of the importance of finding new and inventive ways to engage vulnerable patients in HCV care from the perspective of a clinical nurse practitioner based in London, UK
Treating Patients with Hepatitis C in OST Clinics
Upload date: 04/21/2021 | Duration: 01:40
A description of the significance of HCV treatment in opioid substitution therapy (OST) centers…
A description of the significance of HCV treatment in (OST) centers to the patients who receive it from the perspective of an infectious disease physician in Denmark.
Hepatitis B Reactivation Guide
Upload date: 04/21/2021 | Time to read: 4 minutes
Guidance on HBV reactivation, including details on why it occurs, potential complications, how it is assessed, and treatment considerations for …
Guidance on HBV reactivation, including details on why it occurs, potential complications, how it is assessed, and treatment considerations for patients with HCV/HBV co-infection
Guide to Pre-treatment Laboratory Assessments
Upload date: 04/21/2021 | Time to read: 5 minutes
Recommendations from the AASLD and IDSA on what pretreatment assessments should be considered after HCV diagnosis based on the …
Recommendations from the AASLD and IDSA on what pretreatment assessments should be considered after HCV diagnosis based on the characteristics of the patient
CDC: Determination of Need for Syringe Services Programs
Upload date: 04/21/2021
A CDC resource to provide guidance on how to determine the need for Syringe Services Programs in a state, local, tribal or territorial health …
A CDC resource to provide guidance on how to determine the need for Syringe Services Programs in a state, local, tribal or territorial health department
NASTAD Community Navigation Model and Toolkit
Upload date: 04/21/2021
A toolkit consisting of program protocols, data collection tools and patient education materials to support community health organizations to …
A toolkit consisting of program protocols, data collection tools and patient education materials to support community health organizations to navigate patients through complete diagnostic testing, linkage to care or return to care, treatment, and reinfection prevention after cure
Spanish Hepatitis C Patient Brochure
Upload date: 04/21/2021 | Time to read: 5 minutes
Material centrado en el paciente que contiene detalles básicos sobre el VHC. Esto incluye información sobre causas, síntomas, características …
Material centrado en el paciente que contiene detalles básicos sobre el VHC. Esto incluye información sobre causas, síntomas, características de la enfermedad, tratamiento y reinfección.
